IL285614A
(en )
2021-09-30
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
GB201517215D0
(en )
2015-11-11
Use of cannabinoids in the treatment of inflammatory skin diseases
ZA201807084B
(en )
2019-06-26
Methods of treatment of cholestatic diseases
IL253118A0
(en )
2017-08-31
Methods of treating inflammatory diseases
HK1252037A1
(en )
2019-05-10
Methods of treating inflammatory diseases
HRP20181914T1
(en )
2019-01-11
Treatment of intrahepatic cholestatic diseases
HUE054828T2
(en )
2021-10-28
Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
PL3277280T3
(en )
2024-01-22
Isomyosmine for use in the treatment of autoimmune diseases
ZA201906980B
(en )
2020-11-25
Medical use of artemisinin derivative for treating inflammatory bowel disease
HK1258994A1
(en )
2019-11-22
Methods for treatment of diseases
ZA201808360B
(en )
2020-02-26
Treatment of intrahepatic cholestatic diseases
IL259710A
(en )
2018-07-31
Compositions and methods of treatment for mvid and related diseases
HK1254242A1
(en )
2019-07-12
Composition for treatment of inflammatory bowel disease and atopic dermatitis
GB201515244D0
(en )
2015-10-14
Treatment of inflammatory disease or condition
PL3538132T3
(en )
2021-06-28
Rectal insulin for treatment of inflammatory bowel diseases
IL272604A
(en )
2020-03-31
Methods and compositions for treatment of inflammatory bowel disease
PL3377075T3
(en )
2024-06-24
Composition for the treatment of inflammatory bowel disease
EP3534932C0
(en )
2024-05-22
Treatment of diseases related to igfb3 and its receptor
HUP1500192A2
(en )
2016-11-28
Use of mannooligosaccharides for treating human inflammatory bowel diseases
IL250244A0
(en )
2017-03-30
Preventing and treating inflammatory skin diseases
GB201521918D0
(en )
2016-01-27
Antibodies for treatment and diagnosis of inflammatory bowel disease
GB201514909D0
(en )
2015-10-07
Treatment of autoimmune diseases
GB201504413D0
(en )
2015-04-29
Treatment of disease
GB201418096D0
(en )
2014-11-26
Novel polymorph for use in treatment of inflammatory skin and pruritic disorders
GB201414023D0
(en )
2014-09-24
Treatment of autoimmune diseases